Thus, our study defines a new step in the control of NFAT activation that involves an immunoregulatory function of LRRK2 and has important implications for inflammatory bowel disease.
The results showed that the DNA binding activity of NFAT gradually decreased , with trough value of NFAT binding activity , accounting for 41% of the control, observed at 4d after injury.